Haarlem, Netherlands

Aart Muhlenbruch


 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1993-1998

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aart Muhlenbruch: Innovator in Pharmaceutical Compositions

Introduction

Aart Muhlenbruch is a notable inventor based in Haarlem, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of fast-disintegrating and fast-dissolving compositions. With a total of 2 patents to his name, his work has had a meaningful impact on oral pharmaceutical formulations.

Latest Patents

Aart Muhlenbruch's latest patents include innovative formulations that enhance the effectiveness of pharmaceutical compositions. One of his patents focuses on a granulate for the preparation of fast-disintegrating and fast-dissolving compositions. This granulate contains a drug with a solubility in water of 1:>10 and ≤15 weight percent of a water-dispersible hydrocolloid. Another significant patent involves oral pharmaceutical compositions in unit dosage form, particularly capsules that comprise solid Colloidal Bismuth Subcitrate (CBS). These dosage units are designed to have a packing density of between 0.06 and 0.60 grams of CBS per ml.

Career Highlights

Throughout his career, Aart has worked with prominent companies in the pharmaceutical industry. He has been associated with Yamanouchi Europe B.V. and Gist-Brocades N.V., where he contributed to various innovative projects. His expertise in pharmaceutical formulations has been instrumental in advancing the field.

Collaborations

Aart Muhlenbruch has collaborated with several professionals in his field. Notable coworkers include Bernardus Leonardus Dijkgraaf and Jan Willem Groenendaal, who have worked alongside him on various projects.

Conclusion

Aart Muhlenbruch is a distinguished inventor whose work in pharmaceutical compositions has led to valuable innovations. His patents reflect a commitment to improving drug delivery systems, making a significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…